Source:http://linkedlifedata.com/resource/pubmed/id/11475329
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-7-27
|
pubmed:abstractText |
Metallothioneins (MT) are cytoprotective against the damaging effects of oxygen-derived free radicals. Therefore MT may be involved in defence mechanisms to counter Crohn's disease (CD) and ulcerative colitis (UC).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1023-3830
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
289-93
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
2001
|
pubmed:articleTitle |
Increased expression of metallothionein in inflammatory bowel disease.
|
pubmed:affiliation |
Department of General Surgery, Westfalian WiIhelms-University, Münster, Germany. bruwer@uni-muenster.de
|
pubmed:publicationType |
Journal Article
|